Logical Analysis Report
Key Focus
- The British-Swedish pharmaceutical giant is aiming to produce 2 billion doses of the vaccine, with a view to roll 400 million doses out to the U.S. by October.
AstraZeneca's vaccine has also received multimillion dollar investments from the U.K. government and a $843 million payment from some EU countries, who have secured access to the vaccine should it prove to be effective.
Meanwhile, the Canadian government's National Research Council has signed a deal with China's CanSino Biologics to manufacture its vaccine for clinical trials in Canada this summer - Existing international institutions and agreements will struggle to minimize this 'vaccine nationalism.'"
The research group argued that some governments were already attempting to seize first access through large-scale investments.
"In the U.S., the Biomedical Advanced Research Development Authority (BARDA) has been spreading its investments across a number of vaccine candidates in an effort to reduce the financial risks for pharmaceutical firms and lock in priority access to a successful vaccine," the note's authors said.
BARDA has financial interests in Moderna's candidate vaccine and has invested in early research being conducted by French firm Sanofi and Britain's GlaxoSmithKline.
In May, the U.S. also invested $1 billion in AstraZeneca's potential vaccine, which is being developed by scientists at the University of Oxford - We're all in the same game, so it will happen."
Likening the vaccine development landscape to the space race of the 20th century, Rountree warned that vast government investments would not miraculously pave the way to an effective vaccine.
"Politicians can put aggressive timelines in, and it lends itself to putting a man on the moon," he said
To understand how to read this report, please click here
Knowledge Graph(Read more)
Complex Event Analysis(Read more)
Downloads
Download HLA/Excerpt table in CSV format
Download HLA relevancy table in CSV format
High Level Topics
VACCINECOVID-19COUNTRIESINVESTMENTSHigh Level Abstractions
VACCINE(7, 0 Order)( VACCINE )(7, 0 Order) top( VACCINE, INVESTMENTS )(3, 1st Order) top( VACCINE, HEALTH )(2, 1st Order) top( VACCINE, COVID-19 )(2, 1st Order) top( VACCINE, VIRUS )(1, 1st Order) top( VACCINE, VACCINES )(1, 1st Order) top( VACCINE, SUMMER )(2, 1st Order) top( VACCINE, RACE )(2, 1st Order) top( VACCINE, NATIONALISM )(2, 1st Order) top( VACCINE, UNIVERSITY )(2, 1st Order) top( VACCINE, TIMELINES )(1, 1st Order) top( VACCINE, THREAT )(1, 1st Order) top( VACCINE, SCIENTISTS )(1, 1st Order) topCOVID-19(3, 0 Order)( COVID-19 )(3, 0 Order) topCOUNTRIES(3, 0 Order)( COUNTRIES )(3, 0 Order) topINVESTMENTS(3, 0 Order)( INVESTMENTS )(3, 0 Order) topReferences- ( VACCINE ) top
- ( VACCINE, INVESTMENTS ) top
- (Read more) top
The research group argued that some governments were already attempting to seize first access through large-scale investments.
"In the U.S., the Biomedical Advanced Research Development Authority (BARDA) has been spreading its investments across a number of vaccine candidates in an effort to reduce the financial risks for... - (Read more) top
AstraZeneca's vaccine has also received multimillion dollar investments from the U.K. government and a $843 million payment from some EU countries, who have secured access to the vaccine should it prove to be effective.
Meanwhile, the Canadian government's... - (Read more) top
Likening the vaccine development landscape to the space race of the 20th century, Rountree warned that vast government investments would not miraculously pave the way to an effective vaccine.
"Politicians can put aggressive timelines in, and it lends itself to putting a man on the moon," he said - ( VACCINE, HEALTH ) top
- (Read more) top"Vaccine nationalism" is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned.
Analysts at Eurasia Group speculated that tension over a vaccine would heat up over the summer, predicting a battle for access that will stretch into 2021 or 2022.
"Countries... - (Read more) top
Raveendran noted that while the stockpiling of Covid-19 vaccines would make developing them a commercially viable endeavour, it could come at a cost to public health.
"If we resolve the situation in developed markets and there's still virus running rampant in other parts of the world, this is a problem for all of us," she told CNBC. "We need to be very... - ( VACCINE, COVID-19 ) top
- (Read more) top"Vaccine nationalism" is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned.
Analysts at Eurasia Group speculated that tension over a vaccine would heat up over the... - (Read more) top
Raveendran noted that while the stockpiling of Covid-19 vaccines would make developing them a commercially viable endeavour, it could come at a cost to public health.
"If we resolve the situation in developed markets and there's still virus... - ( VACCINE, VIRUS ) top
- (Read more) top
"If we resolve the situation in developed markets and there's still virus running rampant in other parts of the world, this is a problem for all of us," she told CNBC. "We need to be very aware of how we distribute a very limited resource at the beginning."
Goldin... - ( VACCINE, VACCINES ) top
- (Read more) top
Raveendran noted that while the stockpiling of Covid-19 vaccines would make developing them a commercially viable endeavour, it could come at a cost to public health.
"If we resolve the situation in developed markets and there's still virus running... - ( VACCINE, SUMMER ) top
- (Read more) top
Analysts at Eurasia Group speculated that tension over a vaccine would heat up over the summer, predicting a battle for access that will stretch into 2021 or 2022.
"Countries rich and poor will engage in aggressive procurement efforts with significant political, economic and public health... - (Read more) top
Meanwhile, the Canadian government's National Research Council has signed a deal with China's CanSino Biologics to manufacture its vaccine for clinical trials in Canada this summer. - ( VACCINE, RACE ) top
- (Read more) top"Vaccine nationalism" is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned.
Analysts at Eurasia Group speculated that tension over a vaccine would heat up over the summer, predicting a battle... - (Read more) top
Likening the vaccine development landscape to the space race of the 20th century, Rountree warned that vast government investments would not miraculously pave the way to an effective vaccine.
"Politicians can put aggressive timelines in, and it lends... - ( VACCINE, NATIONALISM ) top
- (Read more) top"Vaccine nationalism" is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned.
Analysts at Eurasia Group speculated that tension... - (Read more) top"Existing international institutions and agreements will struggle to minimize this 'vaccine nationalism.'"
The research group argued that some governments were already attempting to seize first access through large-scale investments.
"In the U.S., the Biomedical Advanced Research Development Authority... - ( VACCINE, UNIVERSITY ) top
- (Read more) top
In May, the U.S. also invested $1 billion in AstraZeneca's potential vaccine, which is being developed by scientists at the University of Oxford. - (Read more) top
Ian Goldin, professor of Globalisation and Development at the University of Oxford and ex-vice president of the World Bank, also warned there would be consequences if countries attempted to make the distribution of a vaccine a national enterprise.
"Some competition... - ( VACCINE, TIMELINES ) top
- (Read more) top
"Politicians can put aggressive timelines in, and it lends itself to putting a man on the moon," he said. - ( VACCINE, THREAT ) top
- (Read more) top
Goldin added that if the virus mutated in parts of the world that were unable to access the vaccine, Covid-19 would once again pose a threat to global public health, even for those who were immunized.
"We don't know how long these vaccines will last and how effective they'll be," he said - ( VACCINE, SCIENTISTS ) top
- (Read more) top
In May, the U.S. also invested $1 billion in AstraZeneca's potential vaccine, which is being developed by scientists at the University of Oxford. - ( COVID-19 ) top
- (Read more) top"Vaccine nationalism" is turning the search for a Covid-19 cure into an arms race, which will ultimately damage the economy and public health, experts have warned.
Analysts at Eurasia Group speculated that tension over a vaccine would heat up over the...
- (Read more) top "Non-profits have put frameworks in place to try and ease this burden, but it's something we as an industry need to address head on."
Raveendran noted that while the stockpiling of Covid-19 vaccines would make developing them a commercially viable endeavour, it could come at a cost to public health.
"If we resolve the situation in developed markets and there's still virus...
- (Read more) topAnthony Fauci, the U.S. government's top infectious disease expert. have cast doubt on Trump's goal.
There are currently at least 160 potential Covid-19 vaccines being tested around the world, according to the WHO..
- ( COUNTRIES ) top
- (Read more) top ... doses out to the U.S. by October.
AstraZeneca's vaccine has also received multimillion dollar investments from the U.K. government and a $843 million payment from some EU countries, who have secured access to the vaccine should it prove to be effective.
Meanwhile, the Canadian government's National Research Council has signed a deal with China's CanSino Biologics...
- (Read more) top... Eurasia's analysts.
Ian Goldin, professor of Globalisation and Development at the University of Oxford and ex-vice president of the World Bank, also warned there would be consequences if countries attempted to make the distribution of a vaccine a national enterprise.
"Some competition is healthy
- (Read more) topwere developing mRNA vaccine technology, which could allow production to be scaled up easily.
However, she added that this might not be enough to offset certain countries'early-access agendas.
"This idea that countries that can afford to, will move first to secure a resource that's scarce and needs to be shared equally definitely raises issues," she said
- ( INVESTMENTS ) top
- (Read more) top... agreements will struggle to minimize this 'vaccine nationalism.'"
The research group argued that some governments were already attempting to seize first access through large-scale investments.
"In the U.S., the Biomedical Advanced Research Development Authority (BARDA) has been spreading its investments across a number of vaccine candidates in an effort to reduce the financial risks for...
- (Read more) top ... is aiming to produce 2 billion doses of the vaccine, with a view to roll 400 million doses out to the U.S. by October.
AstraZeneca's vaccine has also received multimillion dollar investments from the U.K. government and a $843 million payment from some EU countries, who have secured access to the vaccine should it prove to be effective.
Meanwhile, the Canadian government's...
- (Read more) topWe're all in the same game, so it will happen."
Likening the vaccine development landscape to the space race of the 20th century, Rountree warned that vast government investments would not miraculously pave the way to an effective vaccine.
"Politicians can put aggressive timelines in, and it lends itself to putting a man on the moon," he said